
3D Printing Pharmaceuticals - Global and China Top Players Market Share and Ranking 2023
The Global Busbar Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like {playerNamesList}
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for 3D Printing Pharmaceuticals should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China 3D Printing Pharmaceuticals market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States 3D Printing Pharmaceuticals market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Personalized Pharmacy grew percent to account for percent of the total market sales, and Nutrients grew percent.
3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
This report studies and analyses global 3D Printing Pharmaceuticals status and future trends, helps the client to determine the 3D Printing Pharmaceuticals market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for 3D Printing Pharmaceuticals, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global 3D Printing Pharmaceuticals market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global 3D Printing Pharmaceuticals sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China 3D Printing Pharmaceuticals sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global 3D Printing Pharmaceuticals key consuming regions, consumption quantity, consumption value and demand structure
(5) Global 3D Printing Pharmaceuticals key producing regions, capacity, production, and year over year growth
(6) 3D Printing Pharmaceuticals industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Triastek,Inc.
Aprecia
AstraZeneca
FabRx
Multiply Labs
DiHeSys
Merck
Merck KGaA
TNO
Therics
Market segment by Type, covers
FDM
SLS
PB
SLA
SSE
DPE
DOD
MDD
MED
Market segment by Application, can be divided into
Personalized Pharmacy
Nutrients
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe 3D Printing Pharmaceuticals product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global 3D Printing Pharmaceuticals market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China 3D Printing Pharmaceuticals market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of 3D Printing Pharmaceuticals, percent & CAGR, 2018-2029
Chapter 5: 3D Printing Pharmaceuticals industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 3D Printing Pharmaceuticals Definition
1.2 Global 3D Printing Pharmaceuticals Market Size and Forecast
1.2.1 By Consumption Value, Global 3D Printing Pharmaceuticals Market Size,2018-2029
1.2.2 By Sales Quantity, Global 3D Printing Pharmaceuticals Market Size,2018-2029
1.2.3 Global 3D Printing Pharmaceuticals Average Selling Price (ASP),2018-2029
1.3 China 3D Printing Pharmaceuticals Market Size and Forecast
1.3.1 By Consumption Value, China 3D Printing Pharmaceuticals Market Size,2018-2029
1.3.2 By Sales Quantity, China 3D Printing Pharmaceuticals Market Size,2018-2029
1.3.3 China 3D Printing Pharmaceuticals Average Selling Price (ASP), 2018-2029
1.4 Share of China 3D Printing Pharmaceuticals Market with Respect to the Global Market
1.4.1 By Consumption Value, China 3D Printing Pharmaceuticals Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China 3D Printing Pharmaceuticals Market Share in Global, 2018-2029
1.4.3 3D Printing Pharmaceuticals Market Size: China VS Global, 2018-2029
1.5 3D Printing Pharmaceuticals Market Dynamics
1.5.1 3D Printing Pharmaceuticals Market Drivers
1.5.2 3D Printing Pharmaceuticals Market Restraints
1.5.3 3D Printing Pharmaceuticals Industry Trends
1.5.4 3D Printing Pharmaceuticals Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of 3D Printing Pharmaceuticals, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of 3D Printing Pharmaceuticals, Global Market Share by Company, 2018-2023
2.3 3D Printing Pharmaceuticals Average Selling Price (ASP) by Company, 2018-2023
2.4 Global 3D Printing Pharmaceuticals Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global 3D Printing Pharmaceuticals Concentration Ratio
2.6 Global 3D Printing Pharmaceuticals Mergers & Acquisitions, Expansion Plans
2.7 Global 3D Printing Pharmaceuticals Manufacturers Product Type
2.8 Head Office and 3D Printing Pharmaceuticals Production Site of Key Manufacturer
2.9 3D Printing Pharmaceuticals Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of 3D Printing Pharmaceuticals, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of 3D Printing Pharmaceuticals, China Market Share by Company, 2018-2023
3.3 China 3D Printing Pharmaceuticals Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global 3D Printing Pharmaceuticals Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global 3D Printing Pharmaceuticals Capacity by Region
4.3 Global 3D Printing Pharmaceuticals Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global 3D Printing Pharmaceuticals Production by Region, 2018-2029
4.5 Global 3D Printing Pharmaceuticals Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 3D Printing Pharmaceuticals Industry Chain
5.2 3D Printing Pharmaceuticals Upstream Analysis
5.2.1 3D Printing Pharmaceuticals Core Raw Materials
5.2.2 Main Manufacturers of 3D Printing Pharmaceuticals Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 3D Printing Pharmaceuticals Production Mode
5.6 3D Printing Pharmaceuticals Procurement Model
5.7 3D Printing Pharmaceuticals Industry Sales Model and Sales Channels
5.7.1 3D Printing Pharmaceuticals Sales Model
5.7.2 3D Printing Pharmaceuticals Typical Distributors
6 Sights by Type
6.1 3D Printing Pharmaceuticals Classification
6.1.1 FDM
6.1.2 SLS
6.1.3 PB
6.1.4 SLA
6.1.5 SSE
6.1.6 DPE
6.1.7 DOD
6.1.8 MDD
6.1.9 MED
6.2 By Type, Global 3D Printing Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029
6.4 By Type, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029
6.5 By Type, Global 3D Printing Pharmaceuticals Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 3D Printing Pharmaceuticals Segment by Application
7.1.1 Personalized Pharmacy
7.1.2 Nutrients
7.2 By Application, Global 3D Printing Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029
7.4 By Application, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029
7.5 By Application, Global 3D Printing Pharmaceuticals Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global 3D Printing Pharmaceuticals Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029
8.3 By Region, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America 3D Printing Pharmaceuticals & Forecasts, 2018-2029
8.4.2 By Country, North America 3D Printing Pharmaceuticals Market Size Market Share
8.5 Europe
8.5.1 Europe 3D Printing Pharmaceuticals Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe 3D Printing Pharmaceuticals Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific 3D Printing Pharmaceuticals Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific 3D Printing Pharmaceuticals Market Size Market Share
8.7 South America
8.7.1 South America 3D Printing Pharmaceuticals Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America 3D Printing Pharmaceuticals Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global 3D Printing Pharmaceuticals Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029
9.3 By Country, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. 3D Printing Pharmaceuticals Market Size, 2018-2029
9.4.2 By Type, U.S. 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe 3D Printing Pharmaceuticals Market Size, 2018-2029
9.5.2 By Type, Europe 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China 3D Printing Pharmaceuticals Market Size, 2018-2029
9.6.2 By Type, China 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan 3D Printing Pharmaceuticals Market Size, 2018-2029
9.7.2 By Type, Japan 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea 3D Printing Pharmaceuticals Market Size, 2018-2029
9.8.2 By Type, South Korea 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia 3D Printing Pharmaceuticals Market Size, 2018-2029
9.9.2 By Type, Southeast Asia 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India 3D Printing Pharmaceuticals Market Size, 2018-2029
9.10.2 By Type, India 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa 3D Printing Pharmaceuticals Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Triastek,Inc.
10.1.1 Triastek,Inc. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Triastek,Inc. 3D Printing Pharmaceuticals Models, Specifications, and Application
10.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Triastek,Inc. Company Profile and Main Business
10.1.5 Triastek,Inc. Recent Developments
10.2 Aprecia
10.2.1 Aprecia Company Information, Head Office, Market Area, and Industry Position
10.2.2 Aprecia 3D Printing Pharmaceuticals Models, Specifications, and Application
10.2.3 Aprecia 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Aprecia Company Profile and Main Business
10.2.5 Aprecia Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.3.2 AstraZeneca 3D Printing Pharmaceuticals Models, Specifications, and Application
10.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AstraZeneca Company Profile and Main Business
10.3.5 AstraZeneca Recent Developments
10.4 FabRx
10.4.1 FabRx Company Information, Head Office, Market Area, and Industry Position
10.4.2 FabRx 3D Printing Pharmaceuticals Models, Specifications, and Application
10.4.3 FabRx 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 FabRx Company Profile and Main Business
10.4.5 FabRx Recent Developments
10.5 Multiply Labs
10.5.1 Multiply Labs Company Information, Head Office, Market Area, and Industry Position
10.5.2 Multiply Labs 3D Printing Pharmaceuticals Models, Specifications, and Application
10.5.3 Multiply Labs 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Multiply Labs Company Profile and Main Business
10.5.5 Multiply Labs Recent Developments
10.6 DiHeSys
10.6.1 DiHeSys Company Information, Head Office, Market Area, and Industry Position
10.6.2 DiHeSys 3D Printing Pharmaceuticals Models, Specifications, and Application
10.6.3 DiHeSys 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 DiHeSys Company Profile and Main Business
10.6.5 DiHeSys Recent Developments
10.7 Merck
10.7.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.7.2 Merck 3D Printing Pharmaceuticals Models, Specifications, and Application
10.7.3 Merck 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Merck Company Profile and Main Business
10.7.5 Merck Recent Developments
10.8 Merck KGaA
10.8.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
10.8.2 Merck KGaA 3D Printing Pharmaceuticals Models, Specifications, and Application
10.8.3 Merck KGaA 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Merck KGaA Company Profile and Main Business
10.8.5 Merck KGaA Recent Developments
10.9 TNO
10.9.1 TNO Company Information, Head Office, Market Area, and Industry Position
10.9.2 TNO 3D Printing Pharmaceuticals Models, Specifications, and Application
10.9.3 TNO 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 TNO Company Profile and Main Business
10.9.5 TNO Recent Developments
10.10 Therics
10.10.1 Therics Company Information, Head Office, Market Area, and Industry Position
10.10.2 Therics 3D Printing Pharmaceuticals Models, Specifications, and Application
10.10.3 Therics 3D Printing Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Therics Company Profile and Main Business
10.10.5 Therics Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. 3D Printing Pharmaceuticals Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. 3D Printing Pharmaceuticals Market Restraints
Table 3. 3D Printing Pharmaceuticals Market Trends
Table 4. 3D Printing Pharmaceuticals Industry Policy
Table 5. Global 3D Printing Pharmaceuticals Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global 3D Printing Pharmaceuticals Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global 3D Printing Pharmaceuticals Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global 3D Printing Pharmaceuticals Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global 3D Printing Pharmaceuticals Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global 3D Printing Pharmaceuticals Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global 3D Printing Pharmaceuticals Mergers & Acquisitions, Expansion Plans
Table 12. Global 3D Printing Pharmaceuticals Manufacturers Product Type
Table 13. Head Office and 3D Printing Pharmaceuticals Production Site of Key Manufacturer
Table 14. 3D Printing Pharmaceuticals Capacity of Major Manufacturers and Future Plan
Table 15. China 3D Printing Pharmaceuticals Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China 3D Printing Pharmaceuticals Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China 3D Printing Pharmaceuticals Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global 3D Printing Pharmaceuticals Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global 3D Printing Pharmaceuticals Production by Region, 2018-2023, (K Units)
Table 20. Global 3D Printing Pharmaceuticals Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of 3D Printing Pharmaceuticals Upstream (Raw Materials)
Table 22. Global 3D Printing Pharmaceuticals Typical Customers
Table 23. 3D Printing Pharmaceuticals Typical Distributors
Table 24. By Type, Global 3D Printing Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global 3D Printing Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global 3D Printing Pharmaceuticals Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global 3D Printing Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global 3D Printing Pharmaceuticals Consumption Value Market Share, 2018-2029
Table 32. By Country, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global 3D Printing Pharmaceuticals Sales Quantity Market Share, 2018-2029
Table 34. Triastek,Inc. Company Information, Head Office, Market Area, and Industry Position
Table 35. Triastek,Inc. 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 36. Triastek,Inc. 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Triastek,Inc. Company Profile and Main Business
Table 38. Triastek,Inc. Recent Developments
Table 39. Aprecia Company Information, Head Office, Market Area, and Industry Position
Table 40. Aprecia 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 41. Aprecia 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Aprecia Company Profile and Main Business
Table 43. Aprecia Recent Developments
Table 44. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 45. AstraZeneca 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 46. AstraZeneca 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AstraZeneca Company Profile and Main Business
Table 48. AstraZeneca Recent Developments
Table 49. FabRx Company Information, Head Office, Market Area, and Industry Position
Table 50. FabRx 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 51. FabRx 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. FabRx Company Profile and Main Business
Table 53. FabRx Recent Developments
Table 54. Multiply Labs Company Information, Head Office, Market Area, and Industry Position
Table 55. Multiply Labs 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 56. Multiply Labs 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Multiply Labs Company Profile and Main Business
Table 58. Multiply Labs Recent Developments
Table 59. DiHeSys Company Information, Head Office, Market Area, and Industry Position
Table 60. DiHeSys 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 61. DiHeSys 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. DiHeSys Company Profile and Main Business
Table 63. DiHeSys Recent Developments
Table 64. Merck Company Information, Head Office, Market Area, and Industry Position
Table 65. Merck 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 66. Merck 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Merck Company Profile and Main Business
Table 68. Merck Recent Developments
Table 69. Merck KGaA Company Information, Head Office, Market Area, and Industry Position
Table 70. Merck KGaA 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 71. Merck KGaA 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Merck KGaA Company Profile and Main Business
Table 73. Merck KGaA Recent Developments
Table 74. TNO Company Information, Head Office, Market Area, and Industry Position
Table 75. TNO 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 76. TNO 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. TNO Company Profile and Main Business
Table 78. TNO Recent Developments
Table 79. Therics Company Information, Head Office, Market Area, and Industry Position
Table 80. Therics 3D Printing Pharmaceuticals Models, Specifications, and Application
Table 81. Therics 3D Printing Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Therics Company Profile and Main Business
Table 83. Therics Recent Developments
List of Figures
Figure 1. 3D Printing Pharmaceuticals Picture
Figure 2. Global 3D Printing Pharmaceuticals Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global 3D Printing Pharmaceuticals Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global 3D Printing Pharmaceuticals Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China 3D Printing Pharmaceuticals Consumption Value, (US$ million) & (2018-2029)
Figure 6. China 3D Printing Pharmaceuticals Sales Quantity (K Units) & (2018-2029)
Figure 7. China 3D Printing Pharmaceuticals Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China 3D Printing Pharmaceuticals Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China 3D Printing Pharmaceuticals Market Share of Global, 2018-2029
Figure 10. Global 3D Printing Pharmaceuticals Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China 3D Printing Pharmaceuticals Key Participants, Market Share, 2022
Figure 12. Global 3D Printing Pharmaceuticals Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global 3D Printing Pharmaceuticals Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global 3D Printing Pharmaceuticals Production Market Share & Forecast by Region, 2018-2029
Figure 15. 3D Printing Pharmaceuticals Industry Chain
Figure 16. 3D Printing Pharmaceuticals Procurement Model
Figure 17. 3D Printing Pharmaceuticals Sales Model
Figure 18. 3D Printing Pharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 19. FDM
Figure 20. SLS
Figure 21. PB
Figure 22. SLA
Figure 23. SSE
Figure 24. DPE
Figure 25. DOD
Figure 26. MDD
Figure 27. MED
Figure 28. By Type, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Figure 29. By Type, Global 3D Printing Pharmaceuticals Consumption Value Market Share, 2018-2029
Figure 30. By Type, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 31. By Type, Global 3D Printing Pharmaceuticals Sales Quantity Market Share, 2018-2029
Figure 32. By Type, Global 3D Printing Pharmaceuticals Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. Personalized Pharmacy
Figure 34. Nutrients
Figure 35. By Application, Global 3D Printing Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Figure 36. By Application, Global 3D Printing Pharmaceuticals Consumption Value Market Share, 2018-2029
Figure 37. By Application, Global 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 38. By Application, Global 3D Printing Pharmaceuticals Sales Quantity Market Share, 2018-2029
Figure 39. By Application, Global 3D Printing Pharmaceuticals Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 40. By Region, Global 3D Printing Pharmaceuticals Consumption Value Market Share, 2018-2029
Figure 41. By Region, Global 3D Printing Pharmaceuticals Sales Quantity Market Share, 2018-2029
Figure 42. North America 3D Printing Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America 3D Printing Pharmaceuticals Consumption Value Market Share, 2022
Figure 44. Europe 3D Printing Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe 3D Printing Pharmaceuticals Consumption Value Market Share, 2022
Figure 46. Asia Pacific 3D Printing Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific 3D Printing Pharmaceuticals Consumption Value Market Share, 2022
Figure 48. South America 3D Printing Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America 3D Printing Pharmaceuticals Consumption Value Market Share, 2022
Figure 50. Middle East & Africa 3D Printing Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, U.S. 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, U.S. 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 54. Europe 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Europe 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Europe 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 57. China 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, China 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, China 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 60. Japan 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Japan 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Japan 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 63. South Korea 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, South Korea 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, South Korea 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 66. Southeast Asia 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Southeast Asia 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Southeast Asia 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 69. India 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, India 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, India 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 72. Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 73. By Type, Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 74. By Application, Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 75. Research Methodology
Figure 76. Breakdown of Primary Interviews
Figure 77. Bottom-up and Top-down Approaches
Figure 78. Top-down Approaches
Research Methodology:
3D Printing Pharmaceuticals Global and China Top Players Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|